{"transactions":[{"id":737630,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2026-06-15T18:22:39.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 11, 2026 as an option for 15,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share.  The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested."}],"balance_after":15000,"derivative":{"exercise_price":5.53,"expiration_date":"2036-06-10","underlying":"common stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-26-020635","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774926020635/rdgdoc.xml","form_type":"4"}},{"id":932096,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2026-01-23T21:16:04.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 22, 2026 as an option for 35,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.42 per share. The options vest immediately upon grant."}],"balance_after":35000,"derivative":{"exercise_price":5.42,"expiration_date":"2036-01-21","underlying":"common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-26-001915","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774926001915/rdgdoc.xml","form_type":"4"}},{"id":1031137,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2025-09-29T20:10:39.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 25, 2025 as an option for 10,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.05 per share. The options vest in 12 equal monthly installments on the 25th day of each calendar month, beginning October 25, 2025, until such shares are fully vested."}],"balance_after":10000,"derivative":{"exercise_price":6.05,"expiration_date":"2035-09-24","underlying":"common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-030014","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774925030014/rdgdoc.xml","form_type":"4"}},{"id":1035489,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"stock option","published_at":"2025-09-19T19:51:56.000Z","date":"2025-09-18","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 18, 2025 as an option for 10,000 share of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.32 per share. The options vest immediately upon grant."}],"balance_after":10000,"derivative":{"exercise_price":6.32,"expiration_date":"2035-09-17","underlying":"common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-029477","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000143774925029477/rdgdoc.xml","form_type":"4"}},{"id":1245649,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-02-25T21:05:31.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 24, 2025 as an option for 20,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.23 per share. The options vest with respect to the first 25% of such shares on February 24, 2026 and then in 36 equal installments of the balance of the shares of Common Stock on the 24th day of each calendar month thereafter beginning March 24, 2026 until such shares are fully vested."}],"balance_after":20000,"derivative":{"exercise_price":4.23,"expiration_date":"2035-02-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-25-001590","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218025001590/primarydocument.xml","form_type":"4"}},{"id":1429088,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-08-19T20:11:13.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 16, 2024 as an option for 10,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $5.15 per share. The options vest with respect to 1/12th of such shares on September 16, 2024 and then an additional 1/12th of such options vest on the 16th day of each calendar month thereafter until such shares are fully vested."}],"balance_after":10000,"derivative":{"exercise_price":5.15,"expiration_date":"2034-08-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-24-006353","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218024006353/primarydocument.xml","form_type":"4"}},{"id":1483242,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-06-11T20:23:25.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 7, 2024 as an option for 600,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 33.3% of such shares if Clene Inc. has an NDA accepted by the FDA, an additional 33.3% of such shares if Clene Inc. has an NDA approved by the FDA, and the remaining 33.4% of such shares if Clene Inc. achieves $100,000,000 in revenues in connection with the sales of any approved drugs."}],"balance_after":600000,"derivative":{"exercise_price":0.37,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001562180-24-004945","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218024004945/primarydocument.xml","form_type":"4"}},{"id":1483241,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-06-11T20:23:25.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 7, 2024 as an option for 400,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.37 per share. The options vest with respect to the first 25% of such shares on June 7, 2025 and then in 36 equal installments of Common Stock on the 7th day of each calendar month, beginning July 7, 2025, until such shares are fully vested"}],"balance_after":400000,"derivative":{"exercise_price":0.37,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001562180-24-004945","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218024004945/primarydocument.xml","form_type":"4"}},{"id":1839498,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-03T17:50:36.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 29, 2023 as an option for 400,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.90 per share. The options vest with respect to the first 25% of such shares on June 29, 2024 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month beginning July 29, 2024 until such shares are fully vested. If Clene Inc. has an NDA accepted by the FDA, 50% of the option shares shall vest on that date. If the FDA approves the  accepted NDA, the then remaining unvested option shares shall vest on that date."}],"balance_after":400000,"derivative":{"exercise_price":0.9,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001562180-23-005630","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218023005630/primarydocument.xml","form_type":"4"}},{"id":2003183,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-02-21T21:14:47.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 17, 2023 as an option for 125,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.28 per share. The options vest in full on August 17, 2023."}],"balance_after":125000,"derivative":{"exercise_price":1.28,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-23-001571","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218023001571/primarydocument.xml","form_type":"4"}},{"id":2123337,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-11-07T22:14:57.000Z","date":"2022-11-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 4, 2022 as an option for 300,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $1.11 per share. The options vest with respect to the first 25% of such shares on November 4, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 4th day of each calendar month thereafter beginning December 4, 2023 until such shares are fully vested."}],"balance_after":300000,"derivative":{"exercise_price":1.11,"expiration_date":"2032-11-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001562180-22-007531","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218022007531/primarydocument.xml","form_type":"4"}},{"id":2413314,"issuer":{"id":7166,"kind":"organization","name":"Clene Inc.","symbol":"CLNN"},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-02-03T19:15:48.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 1, 2022 as an option for 250,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.96 per share. The options vest  with respect to the first 25% of such shares on February 1, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month, beginning February 1, 2023, until such shares are fully vested"}],"balance_after":250000,"derivative":{"exercise_price":2.96,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001562180-22-001004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000156218022001004/primarydocument.xml","form_type":"4"}},{"id":2480337,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-08T21:00:23.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":176000,"price":1.12,"value":197120.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":176000,"derivative":{"exercise_price":1.12,"exercise_date":"2022-12-07","expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001493152-21-030817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000149315221030817/ownership.xml","form_type":"4"}},{"id":2939772,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":28125,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939771,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-15","kind":"grant","acquired":true,"shares":160000,"price":1.37,"value":219200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 15, 2021, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":160000,"derivative":{"exercise_price":1.37,"exercise_date":"2021-12-15","expiration_date":"2030-12-15","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939770,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":8437,"price":1.35,"value":11389.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":194504,"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2939769,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2020-12-17T21:05:47.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":202941,"source":{"system":"sec-edgar","filing":"0001638599-20-000976","document":"doc4_6959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000976/doc4_6959.xml","form_type":"4"}},{"id":2953206,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-05","kind":"exercise","acquired":false,"shares":70754,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70754,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":70754},"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953205,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"exercise","acquired":false,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":57500,"derivative":{"exercise_price":0,"exercise_date":"2020-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953204,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-05","kind":"exercise","acquired":true,"shares":70754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":174816,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953203,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"sale","acquired":false,"shares":17250,"price":1.5666,"value":27023.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $1.54 - $1.60."}],"balance_after":104062,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":2953202,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-08T21:50:36.000Z","date":"2020-12-04","kind":"exercise","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":121312,"source":{"system":"sec-edgar","filing":"0001638599-20-000948","document":"doc4_6947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000948/doc4_6947.xml","form_type":"4"}},{"id":3300034,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-28T21:26:54.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":132000,"price":0.458,"value":60456.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 28, 2021, while the remaining 2/3 of the shares subject to the award vest monthly on a prorata basis over the following two years."}],"balance_after":132000,"derivative":{"exercise_price":0.458,"exercise_date":"2021-01-28","expiration_date":"2030-01-28","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001638599-20-000106","document":"doc4_6488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859920000106/doc4_6488.xml","form_type":"4"}},{"id":3349586,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Financial Office"}}],"security":"Restricted Stock Unit","published_at":"2019-12-06T15:42:20.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":70754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"}],"balance_after":70754,"derivative":{"exercise_price":0,"exercise_date":"2020-12-05","expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":70754},"source":{"system":"sec-edgar","filing":"0001638599-19-001011","document":"doc4_6380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859919001011/doc4_6380.xml","form_type":"4"}},{"id":3349585,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Financial Office"}}],"security":"Restricted Stock Unit","published_at":"2019-12-06T15:42:20.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":57500,"derivative":{"exercise_price":0,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":57500},"source":{"system":"sec-edgar","filing":"0001638599-19-001011","document":"doc4_6380.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859919001011/doc4_6380.xml","form_type":"4"}},{"id":3349584,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Financial Office"}}],"security":"Common Stock","published_at":"2019-12-06T15:42:20.000Z","date":"2019-12-04","kind":"sale","acquired":false,"shares":17250,"price":0.4102,"value":7075.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average price of shares sold at a price that ranged from $0.4102 - $0.4106."}],"balance_after":63812,"source":{"system":"sec-edgar","filing":"0001638599-19-001011","document":"doc4_6380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859919001011/doc4_6380.xml","form_type":"4"}},{"id":3349583,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Financial Office"}}],"security":"Common Stock","published_at":"2019-12-06T15:42:20.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":81062,"source":{"system":"sec-edgar","filing":"0001638599-19-001011","document":"doc4_6380.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859919001011/doc4_6380.xml","form_type":"4"}},{"id":3741045,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to buy)","published_at":"2018-12-06T11:01:19.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":75000,"price":1.46,"value":109500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 4, 2019, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years."}],"balance_after":75000,"derivative":{"exercise_price":1.46,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001638599-18-001326","document":"doc4_5816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859918001326/doc4_5816.xml","form_type":"4"}},{"id":3741044,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2018-12-06T11:01:19.000Z","date":"2018-12-04","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 50% of the shares subject to the award will vest on the one year anniversary of December 4, 2019 and the remaining 50% of the shares subject to the award will vest on the two year anniversary of December 4, 2020."}],"balance_after":115000,"derivative":{"exercise_price":0,"exercise_date":"2019-12-04","expiration_date":"2028-12-04","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001638599-18-001326","document":"doc4_5816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859918001326/doc4_5816.xml","form_type":"4"}},{"id":4116987,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T23:15:52.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":28125,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001638599-18-000028","document":"doc4_5172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859918000028/doc4_5172.xml","form_type":"4"}},{"id":4116986,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common stock","published_at":"2018-01-02T23:15:52.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":2813,"price":3.4744,"value":9773.4872,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54."}],"balance_after":23562,"source":{"system":"sec-edgar","filing":"0001638599-18-000028","document":"doc4_5172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859918000028/doc4_5172.xml","form_type":"4"}},{"id":4116985,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2018-01-02T23:15:52.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":26375,"source":{"system":"sec-edgar","filing":"0001638599-18-000028","document":"doc4_5172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859918000028/doc4_5172.xml","form_type":"4"}},{"id":4140261,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-06T23:50:46.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":75000,"price":3.52,"value":264000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years."}],"balance_after":75000,"derivative":{"exercise_price":3.52,"exercise_date":"2018-12-06","expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001638599-17-001222","document":"doc4_5123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859917001222/doc4_5123.xml","form_type":"4"}},{"id":4477151,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2017-01-31T02:42:01.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":37500,"derivative":{"exercise_price":0,"exercise_date":"2017-12-31","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001638599-17-000131","document":"doc4_4496.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859917000131/doc4_4496.xml","form_type":"4"}},{"id":4528463,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":38109,"kind":"person","name":"BROWN MORGAN R","position":1,"cik":"0001266062","reported_name":"BROWN MORGAN R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-08T15:48:35.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":50000,"price":3.61,"value":180500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years."}],"balance_after":50000,"derivative":{"exercise_price":3.61,"exercise_date":"2017-12-07","expiration_date":"2016-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001638599-16-001674","document":"doc4_4383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266062/000163859916001674/doc4_4383.xml","form_type":"4"}}]}